Dong Feng Chen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Detachment | 6 | 2008 | 411 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2005 | 1434 | 0.590 |
Why?
|
| Astrocytes | 6 | 2008 | 1266 | 0.580 |
Why?
|
| Central Nervous System | 3 | 2008 | 1354 | 0.520 |
Why?
|
| Nerve Regeneration | 4 | 2005 | 791 | 0.520 |
Why?
|
| Photoreceptor Cells, Vertebrate | 5 | 2008 | 204 | 0.490 |
Why?
|
| Retina | 7 | 2008 | 2611 | 0.480 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2008 | 524 | 0.460 |
Why?
|
| Axons | 3 | 2005 | 1681 | 0.410 |
Why?
|
| Retinal Ganglion Cells | 4 | 2006 | 771 | 0.380 |
Why?
|
| Vimentin | 3 | 2007 | 261 | 0.350 |
Why?
|
| Ephrins | 1 | 2008 | 27 | 0.330 |
Why?
|
| Mucin-1 | 7 | 2007 | 543 | 0.320 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2008 | 33 | 0.320 |
Why?
|
| Retinal Degeneration | 3 | 2008 | 414 | 0.290 |
Why?
|
| Neuroglia | 3 | 2008 | 925 | 0.270 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.260 |
Why?
|
| Integrin alpha1beta1 | 1 | 2004 | 8 | 0.250 |
Why?
|
| Integrin alpha2beta1 | 1 | 2004 | 17 | 0.250 |
Why?
|
| Photobleaching | 1 | 2004 | 31 | 0.250 |
Why?
|
| Neurons | 4 | 2008 | 9325 | 0.240 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 5 | 2008 | 428 | 0.230 |
Why?
|
| Lithium Chloride | 1 | 2003 | 87 | 0.220 |
Why?
|
| Laminin | 1 | 2004 | 418 | 0.220 |
Why?
|
| Cell Differentiation | 3 | 2008 | 11470 | 0.210 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 405 | 0.210 |
Why?
|
| Apoptosis | 5 | 2006 | 9715 | 0.200 |
Why?
|
| Optic Nerve | 1 | 2005 | 548 | 0.200 |
Why?
|
| Ureter | 1 | 2004 | 374 | 0.200 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2005 | 349 | 0.200 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2007 | 643 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2005 | 721 | 0.180 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 520 | 0.180 |
Why?
|
| Retinal Vessels | 1 | 2005 | 769 | 0.180 |
Why?
|
| Dendritic Cells | 4 | 2004 | 2723 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 1121 | 0.170 |
Why?
|
| Mice, Transgenic | 7 | 2008 | 9735 | 0.160 |
Why?
|
| Microglia | 2 | 2007 | 1261 | 0.160 |
Why?
|
| Stem Cells | 2 | 2008 | 3563 | 0.160 |
Why?
|
| Coculture Techniques | 3 | 2008 | 1341 | 0.150 |
Why?
|
| Diabetic Retinopathy | 1 | 2005 | 1205 | 0.140 |
Why?
|
| Mice | 19 | 2008 | 81045 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 10 | 2008 | 21821 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2003 | 1021 | 0.130 |
Why?
|
| Collagen | 1 | 2004 | 2684 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2004 | 1060 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2008 | 23387 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4553 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2938 | 0.120 |
Why?
|
| Biopsy | 1 | 2005 | 6756 | 0.110 |
Why?
|
| Animals | 20 | 2008 | 168561 | 0.100 |
Why?
|
| Cell Fusion | 4 | 2004 | 297 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5095 | 0.090 |
Why?
|
| DNA | 1 | 2004 | 7289 | 0.090 |
Why?
|
| Cell Nucleus | 4 | 2007 | 2968 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2007 | 5180 | 0.090 |
Why?
|
| Insulin | 1 | 2004 | 6575 | 0.080 |
Why?
|
| Ephrin-A3 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Antigens, Neoplasm | 3 | 2007 | 1983 | 0.080 |
Why?
|
| Receptor, EphA7 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Ephrin-A2 | 1 | 2008 | 25 | 0.080 |
Why?
|
| Recoverin | 1 | 2008 | 13 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4751 | 0.080 |
Why?
|
| Gliosis | 2 | 2007 | 243 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 322 | 0.080 |
Why?
|
| Chemokine CCL2 | 2 | 2007 | 617 | 0.070 |
Why?
|
| Mucins | 2 | 2007 | 564 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2007 | 165 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2004 | 1820 | 0.070 |
Why?
|
| Chickens | 1 | 2008 | 865 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2007 | 14554 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 391 | 0.070 |
Why?
|
| beta Catenin | 3 | 2005 | 1058 | 0.070 |
Why?
|
| Cell Count | 2 | 2008 | 1831 | 0.060 |
Why?
|
| Caspases | 2 | 2005 | 928 | 0.060 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2004 | 43 | 0.060 |
Why?
|
| Cell Movement | 4 | 2008 | 5212 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mercaptoethanol | 1 | 2004 | 64 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2005 | 330 | 0.060 |
Why?
|
| Integrin alpha6beta4 | 1 | 2004 | 31 | 0.060 |
Why?
|
| Integrin alpha3beta1 | 1 | 2004 | 53 | 0.060 |
Why?
|
| Cell Transplantation | 2 | 2003 | 477 | 0.060 |
Why?
|
| Bacteriophage lambda | 1 | 2004 | 148 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 599 | 0.060 |
Why?
|
| Kidney Medulla | 1 | 2004 | 182 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 430 | 0.060 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2004 | 178 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2005 | 411 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3847 | 0.060 |
Why?
|
| Cell Survival | 2 | 2004 | 5872 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 781 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 713 | 0.060 |
Why?
|
| Pericytes | 1 | 2005 | 291 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 749 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 898 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 295 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1262 | 0.050 |
Why?
|
| Capillaries | 1 | 2005 | 774 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 514 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2008 | 1167 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10472 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 689 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 1969 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 1 | 2003 | 286 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 1009 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1782 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2005 | 690 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2005 | 1263 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 1866 | 0.050 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 415 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2699 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 1284 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2002 | 625 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2002 | 579 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2008 | 2964 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2723 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 2085 | 0.040 |
Why?
|
| Regeneration | 1 | 2008 | 1485 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1144 | 0.040 |
Why?
|
| Muscles | 1 | 2004 | 1617 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 3769 | 0.040 |
Why?
|
| Lymphocyte Activation | 3 | 2004 | 5519 | 0.040 |
Why?
|
| Antigens | 1 | 2004 | 1462 | 0.040 |
Why?
|
| Disease Progression | 2 | 2005 | 13256 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 4414 | 0.040 |
Why?
|
| Oncogenes | 1 | 2003 | 1263 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3001 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2007 | 18006 | 0.040 |
Why?
|
| Cell Separation | 1 | 2003 | 1749 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2005 | 1771 | 0.040 |
Why?
|
| Leukemia | 1 | 2004 | 1507 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2260 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6608 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 5019 | 0.030 |
Why?
|
| Rats | 3 | 2006 | 24265 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 19223 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2006 | 13029 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 936 | 0.030 |
Why?
|
| Recurrence | 1 | 2005 | 8333 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.030 |
Why?
|
| Time Factors | 2 | 2005 | 40054 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2007 | 960 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3278 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 5705 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3520 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 3 | 2004 | 6313 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.020 |
Why?
|
| Humans | 13 | 2008 | 742088 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2005 | 1539 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2004 | 1368 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3862 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7721 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2002 | 4379 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 5163 | 0.020 |
Why?
|
| Neurocan | 1 | 2008 | 23 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2008 | 159 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 1363 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2007 | 41 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2004 | 3139 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2007 | 47 | 0.020 |
Why?
|
| Brain | 2 | 2005 | 26343 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2003 | 3689 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 964 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 235 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 438 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2005 | 3504 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2005 | 4211 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 834 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1683 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 575 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10163 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 5169 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 41 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 118 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 849 | 0.010 |
Why?
|
| Trans-Activators | 2 | 2003 | 2924 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 180 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 142 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9387 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 197 | 0.010 |
Why?
|
| Female | 4 | 2005 | 379592 | 0.010 |
Why?
|
| HCT116 Cells | 1 | 2003 | 408 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2335 | 0.010 |
Why?
|
| Male | 5 | 2007 | 349538 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 329 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2002 | 517 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 462 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 733 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 759 | 0.010 |
Why?
|
| Obesity | 1 | 2004 | 12705 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 2002 | 182 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2002 | 221 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 53187 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 1740 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2003 | 721 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1547 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 844 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3127 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1158 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 21596 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4322 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 1637 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 2593 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2002 | 1402 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1670 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 85649 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 2513 | 0.010 |
Why?
|
| Aged | 2 | 2005 | 162944 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4465 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6115 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
| Middle Aged | 2 | 2005 | 213127 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6474 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7790 | 0.010 |
Why?
|
| Adult | 2 | 2005 | 213712 | 0.010 |
Why?
|
| DNA Damage | 1 | 2004 | 2423 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3744 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5975 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 6382 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4143 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11363 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 5867 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13814 | 0.010 |
Why?
|
| Mutation | 2 | 2007 | 29717 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16665 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3465 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 4414 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 8425 | 0.000 |
Why?
|
| Cytokines | 1 | 2002 | 7317 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 12071 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2003 | 12164 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13655 | 0.000 |
Why?
|